Showing posts with label rosiglitazone. Show all posts
Showing posts with label rosiglitazone. Show all posts

Friday, 6 December 2019

Treatment Of Diabetes Is Different For Men And Women

Treatment Of Diabetes Is Different For Men And Women.
Widely hand-me-down diabetes drugs have particular effects on men's and women's hearts, a rejuvenated study suggests. Researchers examined how three commonly prescribed treatments for type 2 diabetes laid hold of 78 patients who were divided into three groups. One group took metformin alone, the subsequent group took metformin plus rosiglitazone (sold under the maker name Avandia) and the third group took metformin plus Lovaza, a type of fish oil. Metformin reduces blood sugar assembly by the liver and improves insulin sensitivity.

Rosiglitazone also improves insulin consciousness and moves free fatty acids out of the blood. Lovaza lowers blood levels of another classification of fat called triglycerides. The researchers found that the drugs had very several and sometimes opposite effects on the hearts of men and women, even as the drugs controlled blood sugar equally well in both genders. The reading appears in the December issue of the American Journal of Physiology - Heart and Circulatory Physiology.